DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: A multicenter propensity score matching study
ANNÉE
2023
AUTEURS
C. Borg, V. Vendrely, A. Saint, T. André, P. Vaflard, E. Samalin-Scalzi, S. Pernot, O. Bouche, J. Desrame, C. de la Fouchardiere, D. Smith, F. Ghiringhelli, A. Vienot, E. Francois, J. Taieb, K. Le Malicot, D. Vernerey, A. Meurisse, S. Kim
CONGRÈS/REVUE
BMC Cancer
LIEN PUBLICATIONS ASSOCIÉES